Leuprolide

Label

ClassGnRH agonist

Typical routes in papersDepot or daily on labels

Half-life contextDepot-dependent

EvidenceWidely approved

What it is

Leuprolide (Lupron and others) is the familiar GnRH-agonist depot. Same shutdown logic as triptorelin.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

Medical uses span prostate cancer, endometriosis, fibroids, precocious puberty, and assisted reproduction flare/down-reg protocols.
Not a testosterone booster. After the flare it lowers sex hormones.
Included so “Lupron” searches land on a real explanation.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Sustained GnRH agonism → pituitary desensitization → drop in LH/FSH and downstream sex steroids.

Possible side effects / caveats

Flare symptoms, vasomotor symptoms, bone loss, mood, injection-site issues.

Protocol ranges

Source tier	Amount	Frequency / duration	Notes
Label	Indication-specific depots	Monthly / quarterly / longer	Follow the product used

Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.